| scholarly article | Q13442814 |
| P2093 | author name string | Neelu Puri | |
| Ryan T Pitman | |||
| Luke Wojdyla | |||
| P2860 | cites work | Tankyrase, a poly(ADP-ribose) polymerase at human telomeres | Q22008022 |
| Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres | Q24291989 | ||
| The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182) | Q24292328 | ||
| c-Met is a potentially new therapeutic target for treatment of human melanoma | Q40150516 | ||
| Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells | Q40203284 | ||
| Telomere-based DNA damage responses: a new approach to melanoma | Q40521591 | ||
| Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma | Q40912648 | ||
| Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments. | Q40926739 | ||
| Thymidine dinucleotides induce S phase cell cycle arrest in addition to increased melanogenesis in human melanocytes | Q46718886 | ||
| Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy. | Q52933889 | ||
| Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. | Q54144441 | ||
| Tankyrase promotes telomere elongation in human cells | Q56969704 | ||
| DNA damage and melanogenesis | Q60071776 | ||
| TRF2 overexpression diminishes repair of telomeric single-strand breaks and accelerates telomere shortening in human fibroblasts | Q24301264 | ||
| A human telomeric protein | Q24304466 | ||
| Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling | Q24316697 | ||
| Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2 | Q24317670 | ||
| Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines | Q24804837 | ||
| TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres | Q28119006 | ||
| MITF: master regulator of melanocyte development and melanoma oncogene | Q28256859 | ||
| Shelterin: the protein complex that shapes and safeguards human telomeres | Q28272546 | ||
| Telomeric localization of TRF2, a novel human telobox protein | Q28314941 | ||
| DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion | Q28507823 | ||
| p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2 | Q28609749 | ||
| Protection of mammalian telomeres | Q29618391 | ||
| Stimulation of melanogenesis by DNA oligonucleotides: effect of size, sequence and 5' phosphorylation | Q31871227 | ||
| Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. | Q33356917 | ||
| Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential | Q33924555 | ||
| Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs | Q34361226 | ||
| Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. | Q34384662 | ||
| Evidence that exposure of the telomere 3' overhang sequence induces senescence | Q34470102 | ||
| T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells | Q35048659 | ||
| A role for WRN in telomere-based DNA damage responses | Q35062281 | ||
| Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells | Q35652897 | ||
| Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells | Q35749321 | ||
| The telomeric PARP, tankyrases, as targets for cancer therapy | Q36371977 | ||
| Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21 | Q36612511 | ||
| The universal character of the tumor-associated antigen survivin | Q36975578 | ||
| Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity | Q37153582 | ||
| p53 and E2f: partners in life and death | Q37602510 | ||
| Novel anticancer therapeutics targeting telomerase | Q38030204 | ||
| Tankyrase-targeted therapeutics: expanding opportunities in the PARP family | Q38063790 | ||
| Induction of apoptosis by telomere 3' overhang-specific DNA. | Q38288992 | ||
| Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides | Q38334543 | ||
| Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. | Q38358265 | ||
| T-oligo induces apoptosis in advanced prostate cancer cells | Q39818861 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA damage | Q5205747 |
| P304 | page(s) | 761-771 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma | |
| P478 | volume | 4 |
| Q37437582 | Association of peripheral leukocyte telomere length and its variation with pancreatic cancer and colorectal cancer risk in Chinese population |
| Q38819605 | Beyond Telomerase: Telomere Instability as a Novel Target for Cancer Therapy |
| Q58579018 | Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity |
| Q37045507 | High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness |
| Q36028285 | Low-level infrared laser modulates muscle repair and chromosome stabilization genes in myoblasts. |
| Q39095019 | Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides |
| Q39037222 | Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy |
| Q58696640 | Oligonucleotides Targeting Telomeres and Telomerase in Cancer |
| Q26744221 | Positive and negative effects of cellular senescence during female reproductive aging and pregnancy |
| Q36756860 | SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically |
| Q89597527 | Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations |
| Q35121429 | T-oligo as an anticancer agent in colorectal cancer |
| Q38897533 | TAp63gamma is required for the late stages of myogenesis. |
| Q35784732 | Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition? |
| Q26744808 | Telomere and Telomerase Therapeutics in Cancer |
| Q98158989 | Telomeres and telomerase in oncogenesis |
| Q38288984 | Treating Cancer by Targeting Telomeres and Telomerase |
| Q38310060 | hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang |
Search more.